Key points are not available for this paper at this time.
Metformin may be associated with a decreased risk of many cancer types, but high heterogeneity and risk of publication bias limit confidence in these results. Additional studies in populations without diabetes are needed to better understand the utility of metformin in cancer prevention.
Building similarity graph...
Analyzing shared references across papers
Loading...
Lauren E O’Connor
Maeve Bailey‐Whyte
Manami Bhattacharya
JNCI Journal of the National Cancer Institute
National Institutes of Health
The Ohio State University
National Cancer Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
O’Connor et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69db69975b363cdf1c8359a9 — DOI: https://doi.org/10.1093/jnci/djae021